Wockhardt Plunges on U.S. Ban on Third Drug-Making FactoryBy and
The India-based company had said it was addressing FDA issues
Ban affects drug products Wockhardt makes in Ankleshwar, India
Wockhardt Ltd. plunged the most in six months after its third drug-manufacturing plant in India was banned by the Food and Drug Administration from importing products into the U.S.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.